NCT06677892View on ClinicalTrials.gov

A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium

RecruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

February 24, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

September 1, 2026

Conditions
Cytomegalovirus (CMV)
Interventions
OTHER

No Intervention

This is non-interventional study.

Trial Locations (9)

1070

RECRUITING

Hôpital Erasme, Anderlecht

RECRUITING

Institut Jules Bordet, Anderlecht

1090

RECRUITING

UZBrussel, Jette

1200

RECRUITING

Cliniques Universitaires Saint-Luc, Brussels

2640

RECRUITING

UZA, Edegem

3000

RECRUITING

UZLeuven, Leuven

4000

RECRUITING

CHU de Liège - site Sart Tilman, Liège

5530

RECRUITING

CHU UCL Namur - site Godinne, Yvoir

9000

RECRUITING

UZGent, Ghent

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY